Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Sybrecht

Showing results (51-60 of 119) with videos related to

Pageof 12
Sort By:
Praxis Und Klinik Der Pneumologie|March 1, 1983
[Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]C Ranke, G Schmidt, M Oellerich, et al.
Praktische Anasthesie, Wiederbelebung Und Intensivtherapie|April 1, 1979
[The chest roentgenogram during artificial respiration (author's transl)]G Luska, G W Sybrecht, H Kolbow, et al.
Deutsche Medizinische Wochenschrift (1946)|March 1, 2007
[Pleural puncture]K Purkabiri, K Rentz, G Pindur, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1988
Evaluation of a novel Bayesian method for individualizing theophylline dosageU Stein, M Oellerich, G W Sybrecht, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|November 1, 1985
Determination of theophylline in saliva, using fluorescence polarization immunoassay (FPIA)A Niemann, M Oellerich, G Schumann, et al.
Praxis Und Klinik Der Pneumologie|January 1, 1985
[Pharmacokinetics of theophylline, proxyphylline and diprophylline in a combination preparation in healthy probands]J Schmäschke, M Oellerich, G Schumann, et al.
Oncology Reports|April 18, 2000
Serum anti-p53 antibodies in patients with lung cancerU Mack, D Ukena, M Montenarh, et al.
Pneumologie (Stuttgart, Germany)|May 5, 1999
[Effect of oxygen (FI02: 0.35) on the aerobic capacity in patients with COPD]J Fichter, J Fleckenstein, C Stahl, et al.
Deutsche Medizinische Wochenschrift (1946)|June 6, 2003
[Ineffective anticoagulation prior to elective electric cardioversion for atrial fibrillation. Results of transesophageal echocardiography]M Stopp, C Kristen, G W Sybrecht, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1990
[Therapy of obstructive respiratory tract diseases. V: Mediator antagonists]D Ukena, P Schlimmer, J Vogt, et al.
Pageof 12

Showing results (51-60 of 119) with videos related to

Sort By:
Pageof 12
Praxis Und Klinik Der Pneumologie|March 1, 1983
[Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations]C Ranke, G Schmidt, M Oellerich, et al.
Praktische Anasthesie, Wiederbelebung Und Intensivtherapie|April 1, 1979
[The chest roentgenogram during artificial respiration (author's transl)]G Luska, G W Sybrecht, H Kolbow, et al.
Deutsche Medizinische Wochenschrift (1946)|March 1, 2007
[Pleural puncture]K Purkabiri, K Rentz, G Pindur, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|June 1, 1988
Evaluation of a novel Bayesian method for individualizing theophylline dosageU Stein, M Oellerich, G W Sybrecht, et al.
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|November 1, 1985
Determination of theophylline in saliva, using fluorescence polarization immunoassay (FPIA)A Niemann, M Oellerich, G Schumann, et al.
Praxis Und Klinik Der Pneumologie|January 1, 1985
[Pharmacokinetics of theophylline, proxyphylline and diprophylline in a combination preparation in healthy probands]J Schmäschke, M Oellerich, G Schumann, et al.
Oncology Reports|April 18, 2000
Serum anti-p53 antibodies in patients with lung cancerU Mack, D Ukena, M Montenarh, et al.
Pneumologie (Stuttgart, Germany)|May 5, 1999
[Effect of oxygen (FI02: 0.35) on the aerobic capacity in patients with COPD]J Fichter, J Fleckenstein, C Stahl, et al.
Deutsche Medizinische Wochenschrift (1946)|June 6, 2003
[Ineffective anticoagulation prior to elective electric cardioversion for atrial fibrillation. Results of transesophageal echocardiography]M Stopp, C Kristen, G W Sybrecht, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 15, 1990
[Therapy of obstructive respiratory tract diseases. V: Mediator antagonists]D Ukena, P Schlimmer, J Vogt, et al.
Pageof 12